Document detail
ID

doi:10.1186/s12916-024-03283-5...

Author
Down, Liz Barlow, Melissa Bailey, Sarah E. R. Mounce, Luke T. A. Merriel, Samuel W. D. Watson, Jessica Martins, Tanimola
Langue
en
Editor

BioMed Central

Category

Medicine & Public Health

Year

2024

listing date

3/6/2024

Keywords
ethnicity prostate-specific antigen prostate cancer blood tests health inequities 2% diagnosis cohort aged diagnosed ethnicity cancer black incidence raised prostate result
Metrics

Abstract

Background Black men have higher prostate-specific antigen (PSA) levels and higher prostate cancer incidence and mortality than White men, while Asian men tend to have lower prostate cancer incidence and mortality than White men.

Much of the evidence comes from the USA, and information from UK populations is limited.

Methods This retrospective cohort study used data on patients registered at general practices in England contributing to the Clinical Practice Research Datalink (CPRD) Aurum dataset.

Those eligible were men aged 40 and over with a record of ethnicity and a PSA test result recorded between 2010 and 2017 with no prior cancer diagnosis.

The aim was to assess the incidence of prostate cancer following a raised PSA test result in men from different ethnic groups.

Additionally, incidence of advanced prostate cancer was investigated.

Cancer incidence was estimated from multi-level logistic regression models adjusting for potential confounding factors.

Results 730,515 men with a PSA test were included (88.9% White).

Black men and men with mixed ethnicity had higher PSA values, particularly for those aged above 60 years.

In the year following a raised PSA result (using age-specific thresholds), Black men had the highest prostate cancer incidence at 24.7% (95% CI 23.3%, 26.2%); Asian men had the lowest at 13.4% (12.2%, 14.7%); incidence for White men was 19.8% (19.4%, 20.2%).

The peak incidence of prostate cancer for all groups was in men aged 70–79.

Incidence of prostate cancer diagnosed at an advanced stage was similar between Black and White men.

Conclusions More prostate cancer was diagnosed in Black men with a raised PSA result, but rates of advanced prostate cancer were not higher in this group.

In this large primary care-based cohort, the incidence of prostate cancer in men with elevated PSA levels increases with increasing age, even when using age-adjusted thresholds, with Black men significantly more likely to be diagnosed compared to White or Asian men.

The incidence of advanced stage prostate cancer at diagnosis was similar for Black and White men with a raised PSA result, but lower for Asian men.

Down, Liz,Barlow, Melissa,Bailey, Sarah E. R.,Mounce, Luke T. A.,Merriel, Samuel W. D.,Watson, Jessica,Martins, Tanimola, 2024, Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort study of 730,000 men in primary care in the UK, BioMed Central

Document

Open

Share

Source

Articles recommended by ES/IODE AI

Should we consider Systemic Inflammatory Response Index (SIRI) as a new diagnostic marker for rectal cancer?
inflammation rectal surgery overall survival complication significantly diagnostic value cancer rectal 38 siri